comparemela.com

Latest Breaking News On - Janux therapeutics inc - Page 1 : comparemela.com

Insider Selling: Janux Therapeutics, Inc. (NASDAQ:JANX) CFO Sells 822,721 Shares of Stock

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) CFO Tighe Reardon sold 822,721 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $45,043,974.75. Following the sale, the chief financial officer now directly owns 633,673 shares of […]

China
United-states
America
Immunomodulators-tracir
Engagers-tractr
Tighe-reardon
William-blair
Nasdaq
China-universal-asset-management-co
Janux-therapeutics-inc
Barclays-plc
Allspring-global-investments-holdings

Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Ventures Xi L.P. Avalon Sells 677,279 Shares

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […]

United-states
China
America
Immunomodulators-tracir
Engagers-tractr
Lester-murray-antman
William-blair
Nasdaq
Nisa-investment-advisors
China-universal-asset-management-co
Janux-therapeutics-company-profile
Janux-therapeutics-inc

Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Ventures Xi L.P. Avalon Sells 677,279 Shares

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of Janux Therapeutics stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $37,081,025.25. Following the transaction, the insider now directly owns 3,271,216 shares of […]

United-states
China
America
Immunomodulators-tracir
Lester-murray-antman
Engagers-tractr
William-blair
China-universal-asset-management-co
Nisa-investment-advisors
Nasdaq
Janux-therapeutics-company-profile
Janux-therapeutics-inc

Jay Lichter Sells 1,500,000 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) Director Jay Lichter sold 1,500,000 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $54.75, for a total transaction of $82,125,000.00. Following the sale, the director now directly owns 633,673 shares of the company’s stock, […]

United-states
America
Immunomodulators-tracir
Engagers-tractr
Jay-lichter
William-blair
Artal-group
Janux-therapeutics-company-profile
Virtu-financial
Nasdaq
Securities-exchange-commission
Janus-henderson-group

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH)

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH)
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Kaveri-pohlman
Mark-massaro
Julian-harrison
Akoya-biosciences
Theravance-biopharma
Moonlake-immunotherapeutics
Apogee-therapeutics-inc
Ginkgo-bioworks-holdings
Barclays
Guardant-health
Rani-therapeutics-holdings
Janux-therapeutics-inc

vimarsana © 2020. All Rights Reserved.